Treatment strategies and outcomes for patients with EGFR-mutant non-small cell lung cancer resistant to EGFR tyrosine kinase inhibitors: Focus on novel therapies
- Resource Type
- Review Article
- Source
- In
Lung Cancer August 2022 170:41-51 - Subject
- Language
- ISSN
- 0169-5002